Revolution Medicines Inc (RVMD)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 7.1B
P/E Ratio
0.00
Revenue (TTM)
$ 742K
Volume
0
52W High
$ 62.40
52W Low
$ 29.17
Dividend Yield
0.00%
Beta
1.16
Technicals
50-Day MA
37.3272
200-Day MA
40.8902
52 Week High
62.4
52 Week Low
29.17
About RVMD
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Employees
700
Headquarters
Redwood City, CA
CEO
Dr. Mark A. Goldsmith M.D., Ph.D.
Latest News
Analyzing RVMD with multi timeframe charts - New Guidance & Safe Entry Point Alerts - Newser
8 hours ago • Google News
Interesting RVMD Put And Call Options For April 2026 - Nasdaq
4 hours ago • Google News